Silverfin false false 31/12/2024 01/01/2024 31/12/2024 H M B Hayes 13/06/2023 J N Hilton 13/06/2023 19 April 2025 The principal activity of the company during the financial year was that of management of human resources functions. 14932714 2024-12-31 14932714 bus:Director1 2024-12-31 14932714 bus:Director2 2024-12-31 14932714 core:CurrentFinancialInstruments 2024-12-31 14932714 core:CurrentFinancialInstruments 2023-12-31 14932714 2023-12-31 14932714 core:ShareCapital 2024-12-31 14932714 core:ShareCapital 2023-12-31 14932714 core:RetainedEarningsAccumulatedLosses 2024-12-31 14932714 core:RetainedEarningsAccumulatedLosses 2023-12-31 14932714 bus:OrdinaryShareClass1 2024-12-31 14932714 2024-01-01 2024-12-31 14932714 bus:FilletedAccounts 2024-01-01 2024-12-31 14932714 bus:SmallEntities 2024-01-01 2024-12-31 14932714 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 14932714 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14932714 bus:Director1 2024-01-01 2024-12-31 14932714 bus:Director2 2024-01-01 2024-12-31 14932714 2023-01-01 2023-12-31 14932714 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 14932714 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14932714 (England and Wales)

SANGFROID RESOURCES LTD

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

SANGFROID RESOURCES LTD

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

SANGFROID RESOURCES LTD

BALANCE SHEET

As at 31 December 2024
SANGFROID RESOURCES LTD

BALANCE SHEET (continued)

As at 31 December 2024
Note 2024 2023
£ £
Current assets
Debtors 3 215,861 100
Cash at bank and in hand 725 0
216,586 100
Creditors: amounts falling due within one year 4 ( 226,284) 0
Net current (liabilities)/assets (9,698) 100
Total assets less current liabilities (9,698) 100
Net (liabilities)/assets ( 9,698) 100
Capital and reserves
Called-up share capital 5 100 100
Profit and loss account ( 9,798 ) 0
Total shareholder's (deficit)/funds ( 9,698) 100

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Sangfroid Resources Ltd (registered number: 14932714) were approved and authorised for issue by the Board of Directors on 19 April 2025. They were signed on its behalf by:

H M B Hayes
Director
SANGFROID RESOURCES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
SANGFROID RESOURCES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Sangfroid Resources Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Generator Hub Kings Wharf, The Quay, Exeter, EX2 4AN, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. The company is financially supported by group companies, therefore, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Revenue is recognised on a proportionate basis where the income from a charter or contract directly reflects the percentage of charter completed or the percentage of contract costs incurred.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Related party transactions

During the year the Company entered into a related party transaction with another wholly owned subsidiary. The company has taken the exemption to not disclose further details of this.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Debtors

2024 2023
£ £
Trade debtors 203,494 0
Other debtors 12,367 100
215,861 100

4. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 54,438 0
Amounts owed to Group undertakings 143,805 0
Other creditors 28,041 0
226,284 0

5. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100